Report Cover

Global Genital Herpes Research and Development Pipeline Market 2022 by Company, Regions, Type and Application, Forecast to 2028


The Genital Herpes Research and Development Pipeline market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Genital Herpes Research and Development Pipeline market size will reach USD  million in 2028, growing at a CAGR of  % over the analysis period.
Global key companies of Genital Herpes Research and Development Pipeline include AiCuris GmbH & Co. KG, AlphaVax, Inc., Foamix Pharmaceuticals Ltd., Genocea Biosciences, Inc., and GenVec, Inc., etc. In terms of revenue, the global top four players hold a share over  % in 2021.
Market segmentation
Genital Herpes Research and Development Pipeline market is split by Type and by Application. For the period 2012-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
    Acyclovir
    Aspidasept
    G-103
    GEN-003
    GV-2207
    HerpeCide-I
    HSV-529
    Pritelivir
    SB-105A10
Market segment by Application, can be divided into
    Hospital
    Clinic
Market segment by players, this report covers
    AiCuris GmbH & Co. KG
    AlphaVax, Inc.
    Foamix Pharmaceuticals Ltd.
    Genocea Biosciences, Inc.
    GenVec, Inc.
    Immune Design Corp.
    Immunovaccine, Inc.
    Mymetics Corporation
    NanoBio Corporation
    NanoViricides, Inc.
    PaxVax
    Profectus BioSciences, Inc.
    Sanofi Pasteur SA
    Spider Biotech
    Starpharma Holdings Limited
    Vaccibody AS
    Vaxart, Inc.
    Vical Incorporated.
Market segment by regions, regional analysis covers
    North America
    Europe
    Asia-Pacific (China, Japan, South Korea, Rest of Asia-Pacific)
    South America
    Middle East & Africa
The content of the study subjects, includes a total of 8 chapters:
Chapter 1, to describe Genital Herpes Research and Development Pipeline product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Genital Herpes Research and Development Pipeline, with recent developments and future plans
Chapter 3, the Genital Herpes Research and Development Pipeline competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4, to break the market size data at the region level, with key companies in the key region and Genital Herpes Research and Development Pipeline market forecast, by regions, with revenue, from 2022 to 2028.
Chapter 5 and 6, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2022 to 2028.
Chapter 7 and 8, to describe Genital Herpes Research and Development Pipeline research findings and conclusion, appendix and data source.
1 Market Overview
    1.1 Product Overview and Scope of Genital Herpes Research and Development Pipeline
    1.2 Classification of Genital Herpes Research and Development Pipeline by Type
        1.2.1 Overview: Global Genital Herpes Research and Development Pipeline Market Size by Type: 2022 Versus 2028
        1.2.2 Global Genital Herpes Research and Development Pipeline Revenue Market Share by Type in 2028
        1.2.3 Acyclovir
        1.2.4 Aspidasept
        1.2.5 G-103
        1.2.6 GEN-003
        1.2.7 GV-2207
        1.2.8 HerpeCide-I
        1.2.9 HSV-529
        1.2.10 Pritelivir
        1.2.11 SB-105A10
    1.3 Global Genital Herpes Research and Development Pipeline Market by Application
        1.3.1 Overview: Global Genital Herpes Research and Development Pipeline Market Size by Application: 2022 Versus 2028
        1.3.2 Hospital
        1.3.3 Clinic
    1.4 Global Genital Herpes Research and Development Pipeline Market Size & Forecast
    1.5 Market Drivers, Restraints and Trends
        1.5.1 Genital Herpes Research and Development Pipeline Market Drivers
        1.5.2 Genital Herpes Research and Development Pipeline Market Restraints
        1.5.3 Genital Herpes Research and Development Pipeline Trends Analysis
2 Company Profiles
    2.1 AiCuris GmbH & Co. KG
        2.1.1 AiCuris GmbH & Co. KG Details
        2.1.2 AiCuris GmbH & Co. KG Major Business
        2.1.3 AiCuris GmbH & Co. KG Genital Herpes Research and Development Pipeline Product and Solutions
        2.1.4 AiCuris GmbH & Co. KG Recent Developments and Future Plans
    2.2 AlphaVax, Inc.
        2.2.1 AlphaVax, Inc. Details
        2.2.2 AlphaVax, Inc. Major Business
        2.2.3 AlphaVax, Inc. Genital Herpes Research and Development Pipeline Product and Solutions
        2.2.4 AlphaVax, Inc. Recent Developments and Future Plans
    2.3 Foamix Pharmaceuticals Ltd.
        2.3.1 Foamix Pharmaceuticals Ltd. Details
        2.3.2 Foamix Pharmaceuticals Ltd. Major Business
        2.3.3 Foamix Pharmaceuticals Ltd. Genital Herpes Research and Development Pipeline Product and Solutions
        2.3.4 Foamix Pharmaceuticals Ltd. Recent Developments and Future Plans
    2.4 Genocea Biosciences, Inc.
        2.4.1 Genocea Biosciences, Inc. Details
        2.4.2 Genocea Biosciences, Inc. Major Business
        2.4.3 Genocea Biosciences, Inc. Genital Herpes Research and Development Pipeline Product and Solutions
        2.4.4 Genocea Biosciences, Inc. Recent Developments and Future Plans
    2.5 GenVec, Inc.
        2.5.1 GenVec, Inc. Details
        2.5.2 GenVec, Inc. Major Business
        2.5.3 GenVec, Inc. Genital Herpes Research and Development Pipeline Product and Solutions
        2.5.4 GenVec, Inc. Recent Developments and Future Plans
    2.6 Immune Design Corp.
        2.6.1 Immune Design Corp. Details
        2.6.2 Immune Design Corp. Major Business
        2.6.3 Immune Design Corp. Genital Herpes Research and Development Pipeline Product and Solutions
        2.6.4 Immune Design Corp. Recent Developments and Future Plans
    2.7 Immunovaccine, Inc.
        2.7.1 Immunovaccine, Inc. Details
        2.7.2 Immunovaccine, Inc. Major Business
        2.7.3 Immunovaccine, Inc. Genital Herpes Research and Development Pipeline Product and Solutions
        2.7.4 Immunovaccine, Inc. Recent Developments and Future Plans
    2.8 Mymetics Corporation
        2.8.1 Mymetics Corporation Details
        2.8.2 Mymetics Corporation Major Business
        2.8.3 Mymetics Corporation Genital Herpes Research and Development Pipeline Product and Solutions
        2.8.4 Mymetics Corporation Recent Developments and Future Plans
    2.9 NanoBio Corporation
        2.9.1 NanoBio Corporation Details
        2.9.2 NanoBio Corporation Major Business
        2.9.3 NanoBio Corporation Genital Herpes Research and Development Pipeline Product and Solutions
        2.9.4 NanoBio Corporation Recent Developments and Future Plans
    2.10 NanoViricides, Inc. 
        2.10.1 NanoViricides, Inc. Details
        2.10.2 NanoViricides, Inc. Major Business
        2.10.3 NanoViricides, Inc. Genital Herpes Research and Development Pipeline Product and Solutions
        2.10.4 NanoViricides, Inc. Recent Developments and Future Plans
    2.11 PaxVax
        2.11.1 PaxVax Details
        2.11.2 PaxVax Major Business
        2.11.3 PaxVax Genital Herpes Research and Development Pipeline Product and Solutions
        2.11.4 PaxVax Recent Developments and Future Plans
    2.12 Profectus BioSciences, Inc.
        2.12.1 Profectus BioSciences, Inc. Details
        2.12.2 Profectus BioSciences, Inc. Major Business
        2.12.3 Profectus BioSciences, Inc. Genital Herpes Research and Development Pipeline Product and Solutions
        2.12.4 Profectus BioSciences, Inc. Recent Developments and Future Plans
    2.13 Sanofi Pasteur SA
        2.13.1 Sanofi Pasteur SA Details
        2.13.2 Sanofi Pasteur SA Major Business
        2.13.3 Sanofi Pasteur SA Genital Herpes Research and Development Pipeline Product and Solutions
        2.13.4 Sanofi Pasteur SA Recent Developments and Future Plans
    2.14 Spider Biotech
        2.14.1 Spider Biotech Details
        2.14.2 Spider Biotech Major Business
        2.14.3 Spider Biotech Genital Herpes Research and Development Pipeline Product and Solutions
        2.14.4 Spider Biotech Recent Developments and Future Plans
    2.15 Starpharma Holdings Limited
        2.15.1 Starpharma Holdings Limited Details
        2.15.2 Starpharma Holdings Limited Major Business
        2.15.3 Starpharma Holdings Limited Genital Herpes Research and Development Pipeline Product and Solutions
        2.15.4 Starpharma Holdings Limited Recent Developments and Future Plans
    2.16 Vaccibody AS
        2.16.1 Vaccibody AS Details
        2.16.2 Vaccibody AS Major Business
        2.16.3 Vaccibody AS Genital Herpes Research and Development Pipeline Product and Solutions
        2.16.4 Vaccibody AS Recent Developments and Future Plans
    2.17 Vaxart, Inc.
        2.17.1 Vaxart, Inc. Details
        2.17.2 Vaxart, Inc. Major Business
        2.17.3 Vaxart, Inc. Genital Herpes Research and Development Pipeline Product and Solutions
        2.17.4 Vaxart, Inc. Recent Developments and Future Plans
    2.18 Vical Incorporated.
        2.18.1 Vical Incorporated. Details
        2.18.2 Vical Incorporated. Major Business
        2.18.3 Vical Incorporated. Genital Herpes Research and Development Pipeline Product and Solutions
        2.18.4 Vical Incorporated. Recent Developments and Future Plans
3 Market Competition, by Players
    3.1 Global Genital Herpes Research and Development Pipeline Revenue and Share by Players (2022 & 2028)
    3.2 Genital Herpes Research and Development Pipeline Players Head Office, Products and Services Provided
    3.3 Genital Herpes Research and Development Pipeline Mergers & Acquisitions
    3.4 Genital Herpes Research and Development Pipeline New Entrants and Expansion Plans
4 Global Genital Herpes Research and Development Pipeline Forecast by Region
    4.1 Global Genital Herpes Research and Development Pipeline Market Size by Region: 2022 VS 2028
    4.2 Global Genital Herpes Research and Development Pipeline Market Size by Region, (2022-2028)
    4.3 North America
        4.3.1 Key Companies of Genital Herpes Research and Development Pipeline in North America
        4.3.2 Current Situation and Forecast of Genital Herpes Research and Development Pipeline in North America
        4.3.3 North America Genital Herpes Research and Development Pipeline Market Size and Prospect (2022-2028)
    4.4 Europe
        4.4.1 Key Companies of Genital Herpes Research and Development Pipeline in Europe
        4.4.2 Current Situation and Forecast of Genital Herpes Research and Development Pipeline in Europe
        4.4.3 Europe Genital Herpes Research and Development Pipeline Market Size and Prospect (2022-2028)
    4.5 Asia-Pacific
        4.5.1 Key Companies of Genital Herpes Research and Development Pipeline in Asia-Pacific
        4.5.2 Current Situation and Forecast of Genital Herpes Research and Development Pipeline in Asia-Pacific
        4.5.3 Asia-Pacific Genital Herpes Research and Development Pipeline Market Size and Prospect (2022-2028)
    4.6 South America
        4.6.1 Key Companies of Genital Herpes Research and Development Pipeline in South America
        4.6.2 Current Situation and Forecast of Genital Herpes Research and Development Pipeline in South America
        4.6.3 South America Genital Herpes Research and Development Pipeline Market Size and Prospect (2022-2028)
    4.7 Middle East & Africa
        4.7.1 Key Companies of Genital Herpes Research and Development Pipeline in Middle East & Africa
        4.7.2 Current Situation and Forecast of Genital Herpes Research and Development Pipeline in Middle East & Africa
        4.7.3 Middle East & Africa Genital Herpes Research and Development Pipeline Market Size and Prospect (2022-2028)
5 Market Size Segment by Type
    5.1 Global Genital Herpes Research and Development Pipeline Market Forecast by Type (2022-2028)
    5.2 Global Genital Herpes Research and Development Pipeline Market Share Forecast by Type (2022-2028)
6 Market Size Segment by Application
    6.1 Global Genital Herpes Research and Development Pipeline Market Forecast by Application (2022-2028)
    6.2 Global Genital Herpes Research and Development Pipeline Market Share Forecast by Application (2022-2028)
7 Research Findings and Conclusion
8 Appendix
    8.1 Methodology
    8.2 Research Process and Data Source
    8.3 Disclaimer

List of Tables Table 1. Global Genital Herpes Research and Development Pipeline Revenue by Type, (USD Million), 2022 VS 2028 Table 2. Global Genital Herpes Research and Development Pipeline Revenue by Application, (USD Million), 2022 VS 2028 Table 3. AiCuris GmbH & Co. KG Corporate Information, Head Office, and Major Competitors Table 4. AiCuris GmbH & Co. KG Major Business Table 5. AiCuris GmbH & Co. KG Genital Herpes Research and Development Pipeline Product and Solutions Table 6. AlphaVax, Inc. Corporate Information, Head Office, and Major Competitors Table 7. AlphaVax, Inc. Major Business Table 8. AlphaVax, Inc. Genital Herpes Research and Development Pipeline Product and Solutions Table 9. Foamix Pharmaceuticals Ltd. Corporate Information, Head Office, and Major Competitors Table 10. Foamix Pharmaceuticals Ltd. Major Business Table 11. Foamix Pharmaceuticals Ltd. Genital Herpes Research and Development Pipeline Product and Solutions Table 12. Genocea Biosciences, Inc. Corporate Information, Head Office, and Major Competitors Table 13. Genocea Biosciences, Inc. Major Business Table 14. Genocea Biosciences, Inc. Genital Herpes Research and Development Pipeline Product and Solutions Table 15. GenVec, Inc. Corporate Information, Head Office, and Major Competitors Table 16. GenVec, Inc. Major Business Table 17. GenVec, Inc. Genital Herpes Research and Development Pipeline Product and Solutions Table 18. Immune Design Corp. Corporate Information, Head Office, and Major Competitors Table 19. Immune Design Corp. Major Business Table 20. Immune Design Corp. Genital Herpes Research and Development Pipeline Product and Solutions Table 21. Immunovaccine, Inc. Corporate Information, Head Office, and Major Competitors Table 22. Immunovaccine, Inc. Major Business Table 23. Immunovaccine, Inc. Genital Herpes Research and Development Pipeline Product and Solutions Table 24. Mymetics Corporation Corporate Information, Head Office, and Major Competitors Table 25. Mymetics Corporation Major Business Table 26. Mymetics Corporation Genital Herpes Research and Development Pipeline Product and Solutions Table 27. NanoBio Corporation Corporate Information, Head Office, and Major Competitors Table 28. NanoBio Corporation Major Business Table 29. NanoBio Corporation Genital Herpes Research and Development Pipeline Product and Solutions Table 30. NanoViricides, Inc. Corporate Information, Head Office, and Major Competitors Table 31. NanoViricides, Inc. Major Business Table 32. NanoViricides, Inc. Genital Herpes Research and Development Pipeline Product and Solutions Table 33. PaxVax Corporate Information, Head Office, and Major Competitors Table 34. PaxVax Major Business Table 35. PaxVax Genital Herpes Research and Development Pipeline Product and Solutions Table 36. Profectus BioSciences, Inc. Corporate Information, Head Office, and Major Competitors Table 37. Profectus BioSciences, Inc. Major Business Table 38. Profectus BioSciences, Inc. Genital Herpes Research and Development Pipeline Product and Solutions Table 39. Sanofi Pasteur SA Corporate Information, Head Office, and Major Competitors Table 40. Sanofi Pasteur SA Major Business Table 41. Sanofi Pasteur SA Genital Herpes Research and Development Pipeline Product and Solutions Table 42. Spider Biotech Corporate Information, Head Office, and Major Competitors Table 43. Spider Biotech Major Business Table 44. Spider Biotech Genital Herpes Research and Development Pipeline Product and Solutions Table 45. Starpharma Holdings Limited Corporate Information, Head Office, and Major Competitors Table 46. Starpharma Holdings Limited Major Business Table 47. Starpharma Holdings Limited Genital Herpes Research and Development Pipeline Product and Solutions Table 48. Vaccibody AS Corporate Information, Head Office, and Major Competitors Table 49. Vaccibody AS Major Business Table 50. Vaccibody AS Genital Herpes Research and Development Pipeline Product and Solutions Table 51. Vaxart, Inc. Corporate Information, Head Office, and Major Competitors Table 52. Vaxart, Inc. Major Business Table 53. Vaxart, Inc. Genital Herpes Research and Development Pipeline Product and Solutions Table 54. Vical Incorporated. Corporate Information, Head Office, and Major Competitors Table 55. Vical Incorporated. Major Business Table 56. Vical Incorporated. Genital Herpes Research and Development Pipeline Product and Solutions Table 57. Global Genital Herpes Research and Development Pipeline Revenue (USD Million) by Players (2022 & 2028) Table 58. Global Genital Herpes Research and Development Pipeline Revenue Share by Players (2022 & 2028) Table 59. Genital Herpes Research and Development Pipeline Players Head Office, Products and Services Provided Table 60. Genital Herpes Research and Development Pipeline Mergers & Acquisitions in the Past Five Years Table 61. Genital Herpes Research and Development Pipeline New Entrants and Expansion Plans Table 62. Global Market Genital Herpes Research and Development Pipeline Revenue (USD Million) Comparison by Region (2022 VS 2028) Table 63. Global Genital Herpes Research and Development Pipeline Revenue Market Share by Region (2022-2028) Table 64. Key Companies of Genital Herpes Research and Development Pipeline in North America Table 65. Current Situation and Forecast of Genital Herpes Research and Development Pipeline in North America Table 66. Key Companies of Genital Herpes Research and Development Pipeline in Europe Table 67. Current Situation and Forecast of Genital Herpes Research and Development Pipeline in Europe Table 68. Key Companies of Genital Herpes Research and Development Pipeline in Asia-Pacific Table 69. Current Situation and Forecast of Genital Herpes Research and Development Pipeline in Asia-Pacific Table 70. Key Companies of Genital Herpes Research and Development Pipeline in China Table 71. Key Companies of Genital Herpes Research and Development Pipeline in Japan Table 72. Key Companies of Genital Herpes Research and Development Pipeline in South Korea Table 73. Key Companies of Genital Herpes Research and Development Pipeline in South America Table 74. Current Situation and Forecast of Genital Herpes Research and Development Pipeline in South America Table 75. Key Companies of Genital Herpes Research and Development Pipeline in Middle East & Africa Table 76. Current Situation and Forecast of Genital Herpes Research and Development Pipeline in Middle East & Africa Table 77. Global Genital Herpes Research and Development Pipeline Revenue Forecast by Type (2022-2028) Table 78. Global Genital Herpes Research and Development Pipeline Revenue Forecast by Application (2022-2028) List of Figures Figure 1. Genital Herpes Research and Development Pipeline Picture Figure 2. Global Genital Herpes Research and Development Pipeline Revenue Market Share by Type in 2028 Figure 3. Acyclovir Figure 4. Aspidasept Figure 5. G-103 Figure 6. GEN-003 Figure 7. GV-2207 Figure 8. HerpeCide-I Figure 9. HSV-529 Figure 10. Pritelivir Figure 11. SB-105A10 Figure 12. Genital Herpes Research and Development Pipeline Revenue Market Share by Application in 2028 Figure 13. Hospital Picture Figure 14. Clinic Picture Figure 15. Global Genital Herpes Research and Development Pipeline Market Size, (USD Million): 2022 VS 2028 Figure 16. Global Genital Herpes Research and Development Pipeline Revenue and Forecast (2022-2028) & (USD Million) Figure 17. Genital Herpes Research and Development Pipeline Market Drivers Figure 18. Genital Herpes Research and Development Pipeline Market Restraints Figure 19. Genital Herpes Research and Development Pipeline Market Trends Figure 20. AiCuris GmbH & Co. KG Recent Developments and Future Plans Figure 21. AlphaVax, Inc. Recent Developments and Future Plans Figure 22. Foamix Pharmaceuticals Ltd. Recent Developments and Future Plans Figure 23. Genocea Biosciences, Inc. Recent Developments and Future Plans Figure 24. GenVec, Inc. Recent Developments and Future Plans Figure 25. Immune Design Corp. Recent Developments and Future Plans Figure 26. Immunovaccine, Inc. Recent Developments and Future Plans Figure 27. Mymetics Corporation Recent Developments and Future Plans Figure 28. NanoBio Corporation Recent Developments and Future Plans Figure 29. NanoViricides, Inc. Recent Developments and Future Plans Figure 30. PaxVax Recent Developments and Future Plans Figure 31. Profectus BioSciences, Inc. Recent Developments and Future Plans Figure 32. Sanofi Pasteur SA Recent Developments and Future Plans Figure 33. Spider Biotech Recent Developments and Future Plans Figure 34. Starpharma Holdings Limited Recent Developments and Future Plans Figure 35. Vaccibody AS Recent Developments and Future Plans Figure 36. Vaxart, Inc. Recent Developments and Future Plans Figure 37. Vical Incorporated. Recent Developments and Future Plans Figure 38. Global Genital Herpes Research and Development Pipeline Revenue Market Share by Region (2022-2028) Figure 39. Global Genital Herpes Research and Development Pipeline Revenue Market Share by Region in 2028 Figure 40. North America Genital Herpes Research and Development Pipeline Revenue (USD Million) and Growth Rate (2022-2028) Figure 41. Europe Genital Herpes Research and Development Pipeline Revenue (USD Million) and Growth Rate (2022-2028) Figure 42. Asia-Pacific Genital Herpes Research and Development Pipeline Revenue (USD Million) and Growth Rate (2022-2028) Figure 43. South America Genital Herpes Research and Development Pipeline Revenue (USD Million) and Growth Rate (2022-2028) Figure 44. Middle East & Africa Genital Herpes Research and Development Pipeline Revenue (USD Million) and Growth Rate (2022-2028) Figure 45. Global Genital Herpes Research and Development Pipeline Market Share Forecast by Type (2022-2028) Figure 46. Global Genital Herpes Research and Development Pipeline Market Share Forecast by Application (2022-2028) Figure 47. Methodology Figure 48. Research Process and Data Source

Qualitative Analysis covers:

  • Industry Status and Trends
  • Manufacturer/Company profiles, manufacturing base distribution, sales areas, product introduction, main business, market position and their competitors.
  • Product Development, Technology, Price, Cost, Manufacturing Process and Trends
  • Market segment by regions, types, applications and forecast
  • Market opportunities, potential, government policies and influence factors.
     

Quantitative Analysis covers:

  • Market size (value, sales/output, historical data and forecasts)
  • Sales/output/capacity, revenue, price, gross margin, market share, for top players. Through interviewing each manufacturers,  distributors, traders, dealers and buyers etc.
  • Cost structure, proportion, price trend, gross margin and trend, status and trend, for 10 years
  • Market size by types, regions, applications for 10 years
  • Market forecast based on the potential demand from downstream clients/buyers, government, influence factors and the total economic indication, maybe occur in following years.
     

Data Sources:

Methodology

 

Publisher: GlobalInfoResearch
Chat with us